TRIP13 and neoplasm: Furthermore, western blot analysis showed increased levels of GZMB in DCZ0415‐treated tumours (Fig. 6H), validating our initial observation that TRIP13 inhibition increases levels of GZMB, indicating increased T‐cell infiltration.